查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609753

2024-2032 年日本冠状动脉支架市场报告（按类型、生物材料、输送方式、最终用户和地区）

Japan Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2023年日本冠状动脉支架IMARC Group规模达6.549亿美元。由于年龄增长和不健康饮食和久坐生活方式等生活方式因素，心血管疾病的盛行率不断上升，这主要推动了市场的发展。

冠状动脉支架是用于治疗冠状动脉疾病 (CAD) 的救生医疗设备，冠状动脉疾病是一种常见疾病，斑块在动脉内积聚，减少流向心臟的血液。这些小的网状管通常由金属或可生物降解的材料製成，并在称为血管成形术的过程中插入狭窄或阻塞的冠状动脉中。冠状动脉支架在恢復心肌血流方面发挥着至关重要的作用。它们的工作原理是在狭窄的动脉内扩张，有效地将斑块推开，并为血液自由流动创造更宽的通道。这个过程不仅可以缓解胸痛等症状，还有助于预防心臟病和其他心臟併发症。冠状动脉支架主要有两种：裸金属支架和药物洗脱支架。虽然裸金属支架简单有效，但药物洗脱支架涂有药物，随着时间的推移缓慢释放，降低动脉重新狭窄的风险。近年来，支架技术的进步提高了支架的安全性和有效性，使其成为 CAD 管理的重要工具。

日本冠状动脉支架市场趋势：

日本冠状动脉支架市场受到几个关键因素的推动。首先，冠心病等心血管疾病的盛行率不断上升，推动了对冠状动脉支架的需求。此外，地区人口老化是一个重要的驱动因素，因为老年人更容易患这些疾病。此外，医疗技术的进步和创新支架设计的发展改善了治疗效果，促进了市场成长。此外，人们对微创手术益处的认识不断提高以及患者对微创手术的偏好，促进了冠状动脉支架的采用。此外，日本有利的报销政策激励患者和医疗保健提供者选择支架植入手术。除此之外，医疗保健支出的不断增加，加上个人可支配收入的增加，也促进了冠状动脉支架市场的扩张。此外，製药和医疗器材公司为製造更有效率、更耐用的支架而持续进行的研发工作预计将在预测期内推动日本冠状动脉支架市场的发展。

日本冠状动脉支架市场区隔：

类型见解：

  • 药物洗脱支架
  • 裸金属冠状动脉支架
  • 生物可吸收支架

生物材料见解：

  • 金属生物材料
  • 高分子生物材料
  • 天然生物材料

交付模式见解：

  • 球囊扩张支架
  • 自膨式支架

最终使用者见解：

  • 医院
  • 门诊手术中心
  • 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。一些主要参与者包括：

  • 雅培日本有限公司（雅培实验室）
  • 美敦力日本有限公司（Medtronic plc）
  • 泰尔茂株式会社

本报告回答的关键问题：

  • 日本冠状动脉支架市场迄今表现如何，未来几年又将如何表现？
  • COVID-19 对日本冠状动脉支架市场有何影响？
  • 日本冠状动脉支架市场按类型划分是怎样的？
  • 以生物材料为基础的日本冠状动脉支架市场的细分如何？
  • 日本冠状动脉支架市场以交付方式划分是怎样的？
  • 日本冠状动脉支架市场以最终用户划分是怎样的？
  • 日本冠状动脉支架市场价值链的各个阶段是什么？
  • 日本冠状动脉支架的关键驱动因素和挑战是什么？
  • 日本冠状动脉支架市场的结构如何？
  • 日本冠状动脉支架市场的竞争程度如何？

本报告回答的关键问题：

  • 日本冠状动脉支架市场迄今表现如何，未来几年又将如何表现？
  • COVID-19 对日本冠状动脉支架市场有何影响？
  • 日本冠状动脉支架市场按类型划分是怎样的？
  • 以生物材料为基础的日本冠状动脉支架市场的细分如何？
  • 日本冠状动脉支架市场以交付方式划分是怎样的？
  • 日本冠状动脉支架市场依最终用户划分是怎样的？
  • 日本冠状动脉支架市场价值链的各个阶段是什么？
  • 日本冠状动脉支架的关键驱动因素和挑战是什么？
  • 日本冠状动脉支架市场的结构如何？
  • 日本冠状动脉支架市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：日本冠状动脉支架市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章：日本冠状动脉支架市场格局

  • 历史与当前市场趋势（2018-2023）
  • 市场预测（2024-2032）

第 6 章：日本冠状动脉支架市场 - 细分：按类型

  • 药物洗脱支架
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 裸金属冠状动脉支架
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 生物可吸收支架
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 7 章：日本冠状动脉支架市场 - 细分：生物材料

  • 金属生物材料
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 高分子生物材料
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 天然生物材料
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 8 章：日本冠状动脉支架市场 - 细分：以交付方式

  • 球囊扩张支架
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 自膨式支架
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 9 章：日本冠状动脉支架市场 - 细分：按最终用户划分

  • 医院
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 门诊手术中心
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 其他的
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 10 章：日本冠状动脉支架市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 11 章：关键参与者简介

  • Abbott Japan Co. Ltd. (Abbott Laboratories)
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Medtronic Japan Co. Ltd. (Medtronic plc)
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Terumo Corporation
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

请注意，这只是关键参与者的部分列表，报告中提供了完整列表。

第 12 章：日本冠状动脉支架市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 13 章：附录

简介目录
Product Code: SR112024A18300

Japan coronary stents market size reached US$ 654.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 986.7 Million by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032. The growing prevalence of cardiovascular diseases on account of advancing age and lifestyle factors such as unhealthy diets and sedentary lifestyles, is primarily driving the market.

Coronary stents are life-saving medical devices used to treat coronary artery disease (CAD), a common condition where plaque builds up inside the arteries, reducing blood flow to the heart. These small, mesh-like tubes are typically made of metal or biodegradable materials and are inserted into narrowed or blocked coronary arteries during a procedure called angioplasty. Coronary stents serve a crucial role in restoring blood flow to the heart muscle. They work by expanding within the narrowed artery, effectively pushing aside the plaque and creating a wider passage for blood to flow freely. This process not only relieves symptoms like chest pain but also helps prevent heart attacks and other cardiac complications. There are two main types of coronary stents: bare-metal stents and drug-eluting stents. While bare-metal stents are simple and effective, drug-eluting stents are coated with medications that slowly release over time, reducing the risk of re-narrowing the artery. In recent years, advances in stent technology have improved their safety and effectiveness, making them an essential tool in the management of CAD.

Japan Coronary Stents Market Trends:

The coronary stents market in Japan is driven by several key factors. Firstly, the increasing prevalence of cardiovascular diseases, such as CAD, has propelled the demand for coronary stents. Moreover, the aging regional population is a significant driver, as elderly individuals are more susceptible to these ailments. Additionally, advancements in medical technology and the development of innovative stent designs have led to improved treatment outcomes, fostering market growth. Furthermore, the rising awareness about the benefits of minimally invasive procedures and the preference for them among patients has boosted the adoption of coronary stents. Furthermore, favorable reimbursement policies in Japan have incentivized both patients and healthcare providers to opt for stent implantation procedures. Apart from this, the escalating healthcare expenditure, coupled with the increasing disposable income of individuals, has contributed to the expansion of the coronary stents market. Additionally, the ongoing R&D efforts by pharmaceutical and medical device companies to create more efficient and durable stents are expected to drive the coronary stents market in Japan during the forecast period.

Japan Coronary Stents Market Segmentation:

Type Insights:

  • Drug-Eluting Stents
  • Bare-Metal Coronary Stents
  • Bioabsorbable Stents

Biomaterial Insights:

  • Metallic Biomaterial
  • Polymeric Biomaterial
  • Natural Biomaterial

Mode of Delivery Insights:

  • Balloon-Expandable Stents
  • Self-Expanding Stents

End User Insights:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

  • Abbott Japan Co. Ltd. (Abbott Laboratories)
  • Medtronic Japan Co. Ltd. (Medtronic plc)
  • Terumo Corporation

Key Questions Answered in This Report:

  • How has the Japan coronary stents market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan coronary stents market?
  • What is the breakup of the Japan coronary stents market on the basis of type?
  • What is the breakup of the Japan coronary stents market on the basis of biomaterial?
  • What is the breakup of the Japan coronary stents market on the basis of mode of delivery?
  • What is the breakup of the Japan coronary stents market on the basis of end user?
  • What are the various stages in the value chain of the Japan coronary stents market?
  • What are the key driving factors and challenges in the Japan coronary stents?
  • What is the structure of the Japan coronary stents market and who are the key players?
  • What is the degree of competition in the Japan coronary stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Coronary Stents Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Coronary Stents Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Coronary Stents Market - Breakup by Type

  • 6.1 Drug-Eluting Stents
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Bare-Metal Coronary Stents
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Bioabsorbable Stents
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)

7 Japan Coronary Stents Market - Breakup by Biomaterial

  • 7.1 Metallic Biomaterial
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Polymeric Biomaterial
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Natural Biomaterial
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)

8 Japan Coronary Stents Market - Breakup by Mode of Delivery

  • 8.1 Balloon-Expandable Stents
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Self-Expanding Stents
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)

9 Japan Coronary Stents Market - Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Others
    • 9.3.1 Historical and Current Market Trends (2018-2023)
    • 9.3.2 Market Forecast (2024-2032)

10 Japan Coronary Stents Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Abbott Japan Co. Ltd. (Abbott Laboratories)
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Medtronic Japan Co. Ltd. (Medtronic plc)
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Terumo Corporation
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events

Please note that this is only a partial list of the key players, and the complete list is provided in the report.

12 Japan Coronary Stents Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix